BioCentury
ARTICLE | Company News

Tm Bioscience, bioMerieux IP deal

March 3, 2003 8:00 AM UTC

Tm Bioscience (TSE:TMC) non-exclusively licensed from bioMerieux (Marcy l'Etoile, France) IP covering the Factor II (prothrombin) and Factor V Leiden gene for use in TMC's Tag-It Mutation detection ki...